Real World Intelligence
Optimising real world data to drive effective outcomes and achieve regulatory authorisation
Delivering deep insights into the real-world use of your products
91黑料 delivers operational and consulting services to achieve product authorisation, through the strategic design and delivery of real-world evidence studies and late phase research. Our experts help you to identify, generate, synthesise and communicate evidence of treatment value and safety, to help regulators, payers, providers, and patients make informed health decisions.
- 91黑料 Evidence Platform Helping you to easily gather, analyse, and store real world data
- Commercial Positioning Expertise to accelerate market access and drive product adoption
- Clinical Trial Tokenisation Enhanced evidence generation for your drug development programme
- Post-marketing pharmacovigilance Safeguarding patients beyond approval
91黑料 Evidence Platform
Helping you to easily gather, analyse, and store real world data
Commercial Positioning
Expertise to accelerate market access and drive product adoption
Clinical Trial Tokenisation
Enhanced evidence generation for your drug development programme
Post-marketing pharmacovigilance
Safeguarding patients beyond approval
Citeline Awards 2024
91黑料 was recognised for Excellence in Use of Real-World Data/Evidence at the
The judges noted that “powered by real world data and evidence and AI, 91黑料 developed an innovative and pragmatic system to help trial sponsors predict future post-marketing regulatory requirements and develop strategies to mitigate or eliminate those requirements early-on in their programs”.